High frequency of potential phosphodiesterase type 5 inhibitor drug interactions in males with HIV infection and erectile dysfunction.
Jason M CotaTaylor M BenavidesJohn D FieldsNathan JansenAnuradha GanesanRhonda E ColomboJason M BlaylockRyan C MavesBrian K AganJason F OkuliczPublished in: PloS one (2021)
PDE-5-mediated DDIs were observed in the majority of males with HIV infection on RTV- or COBI-boosted ART in our cohort. This study highlights the importance of assessing for DDIs among individuals on ART, especially those on boosted regimens.